Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

MitoQ begins phase II study to reduce liver damage in HCV patients

Feb. 8, 2007

AGI reports initial phase II results in functional diarrhea, functional dyspepsia

Feb. 5, 2007

Recent patents disclose novel therapeutic agents for gastrointestinal disorders

Feb. 5, 2007

Kyowa Hakko and Zeria collaborate on Asacol in Japan

Feb. 1, 2007

Locteron begins phase IIa trial for chronic hepatitis C

Feb. 1, 2007

PEG-Interferon lambda begins phase I study

Feb. 1, 2007

Recent patents disclose novel therapeutic agents for HCV infection

Feb. 1, 2007

Pariet approved in Japan for H. pylori eradication

Jan. 31, 2007

Oral entry inhibitor SP-10 shows antiviral activity in HCV

Jan. 31, 2007

Copegus approved for use in combination with Pegasys in Japan

Jan. 30, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026